Related references
Note: Only part of the references are listed.Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies
Jia-Yi Dong et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
In Vitro Cytochrome P450-Mediated Metabolism of Exemestane
Landry K. Kamdem et al.
DRUG METABOLISM AND DISPOSITION (2011)
In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole
Landry K. Kamdem et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
The pros and cons of phytoestrogens
Heather B. Patisaul et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2010)
Prospective study of the association between grapefruit intake and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Elizabeth A. Spencer et al.
CANCER CAUSES & CONTROL (2009)
Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer
Christine M. Mueller et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2008)
Use of complementary therapies by Australian women with breast cancer
T. Kremser et al.
BREAST (2008)
Familial and perceived risk of breast cancer in relation to use of complementary medicine
Cynthia D. Myers et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Phytoestrogens and breast cancer: a complex story
W. G. Helferich et al.
INFLAMMOPHARMACOLOGY (2008)
Prospective study of grapefruit intake and risk of breast cancer in postmenopausal women: the Multiethnic Cohort Study
K. R. Monroe et al.
BRITISH JOURNAL OF CANCER (2007)
Role of complementary and alternative medicine in the care of patients with breast cancer: Report of the European Society of Mastology (EUSOMA) Workshop, Florence, Italy, December 2004
Michael Baum et al.
EUROPEAN JOURNAL OF CANCER (2006)
Herb-drug interactions in oncology: Focus on mechanisms of induction
Irma Meijerman et al.
ONCOLOGIST (2006)
Levels of commitment: Exploring complementary therapy use by women with breast cancer
Lynda G. Balneaves et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2006)
Complementary and alternative medicine use in breast cancer patients in Europe
A Molassiotis et al.
SUPPORTIVE CARE IN CANCER (2006)
Unconventional anticancer agents: A systematic review of clinical trials
AJ Vickers et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The use of complementary and alternative medicine among California adults with and without cancer
MS Goldstein et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2005)
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients
I Bairati et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
In vitro letrozole N-dealkylation is mainly catalyzed by human cytochrome P450 (CYP) 3A.
Z Desta et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Potential health risks of complementary alternative medicines in cancer patients
U Werneke et al.
BRITISH JOURNAL OF CANCER (2004)
Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey
G Nagel et al.
SUPPORTIVE CARE IN CANCER (2004)
Assessing websites on complementary and alternative medicine for cancer
K Schmidt et al.
ANNALS OF ONCOLOGY (2004)
Are herbal remedies and dietary supplements safe and effective for breast cancer patients?
A Cassidy
BREAST CANCER RESEARCH (2003)
Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes:: Formation of the 4-hydroxy, 4′-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen
HK Crewe et al.
DRUG METABOLISM AND DISPOSITION (2002)
Popularity of complementary and alternative medicine in Japan: a telephone survey
H Yamashita et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2002)
Use of unconventional medicine in Italy: a nation-wide survey
F Menniti-Ippolito et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Use of alternative/complementary therapy in breast cancer patients -: a psychological perspective
R Moschèn et al.
SUPPORTIVE CARE IN CANCER (2001)
Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions
H Boon et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites
KT Morris et al.
AMERICAN JOURNAL OF SURGERY (2000)
Share Paper
